医学
免疫疗法
癌症
细胞因子
癌症免疫疗法
肿瘤微环境
免疫学
内科学
作者
Aliyah Pabani,Justin F. Gainor
标识
DOI:10.1158/1078-0432.ccr-22-1837
摘要
The clinical development of cytokines as cancer therapeutics has been limited due to significant toxicities generally observed with systemic administration. This narrow therapeutic window, together with relatively modest efficacy, has made natural cytokines unattractive drug candidates. Immunocytokines represent a class of next-generation cytokines designed to overcome the challenges associated with traditional cytokines. These agents seek to improve the therapeutic index of cytokines by using antibodies as vehicles for the targeted delivery of immunomodulatory agents within the local tumor microenvironment (TME). Various molecular formats and cytokine payloads have been studied. In this review, we provide an overview of the rationale, preclinical support, and current clinical development strategies for immunocytokines.
科研通智能强力驱动
Strongly Powered by AbleSci AI